Want to know the latest news and articles posted on Telix Pharmaceuticals?
Then subscribe to their feed now! You can receive their updates by email, via mobile or on your personal news page on this website.
See what they recently published below.
Website title: Home - Telix Pharmaceuticals
Is this your feed? Claim it!
Melbourne (Australia) and Indianapolis, IN (United States) | September 2, 2026
The Phase 3 BiPASS study of Illuccix® and Gozellix® for prostate cancer imaging in the pre-biopsy setting has completed enrollment of 350 patients. Telix has positively engaged with the...Melbourne (Australia) and Indianapolis, IN (United States) | September 1, 2026
• David Gill appointed Chair of the Telix Board, effective immediately.
• Mr. Gill joined Telix as a Non-Executive Director in May 2026, with the intention that he would become Chair.
• Dr. Mark Nelson will continue to serve...
Melbourne (Australia) and Indianapolis, IN (United States) | August 20, 2026
Telix today announces its financial results for the period ended June 30, 2026.
H1 2026 key results Group performanceMelbourne (Australia) and Indianapolis, IN (United States) | August 5, 2026
Telix today advises that it will host a Research and Development (R&D) Day on Tuesday, September 22, 2026, from 8:30 a.m. to 12:30 p.m. EDT in New York City.
Institutional investors and analysts are invited to regis...